Background Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated
inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, …

Background Functional impairment of interferon, a natural antiviral component of the
immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to …

Background Baricitinib and dexamethasone have randomised trials supporting their use for
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …

Purpose of Review We reviewed the available literature on mpox in People with HIV (PWH).
We highlight special considerations of mpox infection related to epidemiology, clinical …

Importance Current data identifying COVID-19 risk factors lack standardized outcomes and
insufficiently control for confounders. Objective To identify risk factors associated with COVID-…

Background While vaccines have established utility against COVID-19, phase 3 efficacy studies
have generally not comprehensively evaluated protection provided by previous infection …

The COVID-19 pandemic has disproportionately impacted racial and ethnic minority
communities, particularly African American and Latino communities. The impacts of social …

Background In the Southeastern United States, the 2022 mpox outbreak disproportionately
impacted people who are black and people with HIV (PWH). Methods We analyzed a cohort …

We explored experiences with telemedicine among persons with HIV (PWH) during the first
wave of the coronavirus disease 2019 (COVID-19) pandemic. A convenience sample of …

Background HIV disproportionally impacts Latino sexual minority men (SMM). Uptake of pre-exposure
prophylaxis (PrEP), an effective biomedical intervention to prevent HIV, is low in …